2004
DOI: 10.1038/nrd1549
|View full text |Cite
|
Sign up to set email alerts
|

Docking and scoring in virtual screening for drug discovery: methods and applications

Abstract: An investigation has been carried out to find out the anti cancerous compounds can exhibit anti diabetic against aldose reductase. Diabetes and cancer are common diseases worldwide. In our study we have taken 17 anti cancerous compounds from inhouse chalcones database to perform docking studies. It reveals that there are some compounds which are binding with high affinity than the average docking score-126.048 kcal/mol of ligands of the 1AH3 protein. The anti cancer compounds exhibit high docking score than th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
2,222
0
67

Year Published

2005
2005
2021
2021

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 3,198 publications
(2,405 citation statements)
references
References 131 publications
8
2,222
0
67
Order By: Relevance
“…Ligand docking is a well established computational technique that has been successfully employed in medicinal chemistry to assist drug discovery and lead optimization efforts [1]. The aim of ligand docking is to find the binding pose of a small organic molecule in a receptor pocket, and, if multiple ligands are compared, an estimate of the ligand binding affinity, referred to as the docking score.…”
Section: Introductionmentioning
confidence: 99%
“…Ligand docking is a well established computational technique that has been successfully employed in medicinal chemistry to assist drug discovery and lead optimization efforts [1]. The aim of ligand docking is to find the binding pose of a small organic molecule in a receptor pocket, and, if multiple ligands are compared, an estimate of the ligand binding affinity, referred to as the docking score.…”
Section: Introductionmentioning
confidence: 99%
“…The popular structure-based approaches require the availability of a 3D structure for the biological target of interest, this information permitting the use of methods based on de novo design or ligand-protein docking [5][6][7], these methods becoming widely used with the continuing growth in the availability of 3D protein data [8,9]. If the necessary 3D information is not available then it may be possible to identify the structural requirements for activity by analysis of those structures that have already been shown to be active.…”
Section: Introductionmentioning
confidence: 99%
“…Virtual screening is a method applied to identify new chemical entities and structural scaffolds for a protein target [52,53]. The virtual screening process is carried out in virtual screening work flow of the Schrödinger suite.…”
Section: Virtual Screening and Pharmacokinetic Properties Calculationmentioning
confidence: 99%